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The renin-angiotensin system (RAS), in addition to its
endocrine functions, plays a role within individual
tissues such as the brain. The brain RAS is thought
to control blood pressure through effects on fluid
intake, vasopressin release, and sympathetic nerve
activity (SNA), and may regulate metabolism through
mechanisms which remain undefined. We used
a double-transgenic mouse model that exhibits
brain-specific RAS activity to examine mechanisms
contributing to fluid and energy homeostasis. The
mice exhibit high fluid turnover through increased
adrenal steroids, which is corrected by adrenalec-
tomy and attenuated by mineralocorticoid receptor
blockade. They are also hyperphagic but lean
because of a marked increase in body temperature
and metabolic rate, mediated by increased SNA
and suppression of the circulating RAS. b-adrenergic
blockade or restoration of circulating angiotensin-II,
but not adrenalectomy, normalized metabolic rate.
Our data point to contrasting mechanisms by which
the brain RAS regulates fluid intake and energy
expenditure.
INTRODUCTION
Despite a growing body of evidence supporting the existence of
local, tissue-level expression and activity of the renin-angio-
tensin system (RAS), there persists a general lack of appreciation
for the roles of these autocrine/paracrine systems both in normal
physiology and in pathophysiological states. Indeed, major roles
for the RAS in the vasculature, heart, and kidney in the develop-
ment and maintenance of hypertension and its sequelae have
been reported (Paul et al., 2006).
The brain, like several peripheral organ systems, expresses all
components of the RAS, and generates angiotensin peptides
locally. There is evidence to support the hypothesis that angio-Cell Mtensin peptides may be utilized as neurotransmitters, acting in
certain cardiovascular control substructures of the brain
(reviewed in Grobe et al., 2008; Ferguson et al., 2001; and John-
son, 1985). Through autocrine/paracrine signaling and acting as
a neurotransmitter, the brain RAS is thought to control blood
pressure (Bickerton and Buckley, 1961); fluid balance (Booth,
1968; Daniels et al., 1969; Epstein et al., 1970); learning,memory,
and anxiety (reviewed inWright et al., 2008); andmetabolic func-
tion (Porter et al., 2003; Porter and Potratz, 2004). Abnormalities
of thebrainRAS leading to its overactivity havebeen implicated in
several forms of genetic and experimental hypertension (Veera-
singham and Raizada, 2003). Despite the recognition that the
brain RAS is involved in these processes, the efferent mecha-
nisms mediating these functions remain unclear.
To examine the functions of the brain RAS, we developed
a double-transgenic mouse model expressing human renin
controlled by the neuron-specific synapsin promoter (sR) and
the human angiotensinogen gene controlled by its own promoter
(A) (Sakai et al., 2007). Due to the strict species specificity of the
renin-mediated cleavage of angiotensinogen, the human angio-
tensinogen protein is only cleaved into angiotensin I in the pres-
ence of human renin, so, despite a widespread expression of
human angiotensinogen, RAS hyperactivity only occurs in
tissues where both transgenes are active. Double-transgenic
sRA mice exhibit RAS hyperactivity only in the brain regions
where angiotensinogen is normally expressed, and thus this
model may phenocopy hypertension caused by increased brain
RAS activity. Using this unique sRA animal model, we have iden-
tified divergent efferent signaling mechanisms that mediate the
marked hydromineral andmetabolic consequences of increased
brain RAS activity. The physiological relevance of our model was
confirmed by showing similar metabolic consequences in an
independent experimental model of brain RAS-mediated hyper-
tension.RESULTS
sRA Mice Exhibit Polydipsia and Polyuria
sRA mice exhibit robust polydipsia and polyuria (Figures 1A and
1B). Remarkably, they consume the equivalent of their own bodyetabolism 12, 431–442, November 3, 2010 ª2010 Elsevier Inc. 431
Figure 1. Mice with Brain Renin-Angio-
tensin System Hyperactivity Exhibit Potent
Hydromineral Phenotypes
(A) Ad libitum 24 hr intake volumes for tap water
and 0.15 M NaCl solutions (control, n = 6; sRA,
n = 3).
(B) NaCl preference, total fluid intake, total sodium
intake, urine volume, urine sodium concentration
(UNaC), and urine osmolality from sRA and control
littermate mice offered ad libitum access to
varying concentrations of NaCl drink solution,
distilled water, and standard chow (control, n = 6;
sRA, n = 6).
(C) Renal sympathetic nerve activity (RSNA)
(males only; control, n = 7; sRA, n = 6).
(D) Blood hematocrit (control, n = 9; sRA, n = 8).
(E) Serum osmolality (control, n = 10; sRA, n = 6),
potassium concentration, and sodium concentra-
tion (control, n = 17; sRA, n = 15).
(F) Analysis of pup survival to birth and to weaning.
(G) Plasma arginine vasopressin (AVP) concentra-
tions at baseline and following a 4 hr water restric-
tion (n = 4 for all).
(H) Total 24 hr sodium intake, preference for
0.15 M NaCl, fluid intake, and urine volume after
treatment with conivaptan (saline, n = 5; conivap-
tan, n = 6). *p < 0.05 versus control, or sRA+Saline.
All data are mean ± SEM. See also Figure S1.
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in a two-bottle choice paradigm. To examine whether the
elevated intake of fluids in sRA mice was dependent upon the
concentration of the NaCl solutions offered, we performed
a NaCl preference aversion experiment by observing 24 hr
intakes of water and a range of hypotonic to hypertonic NaCl
drink solutions (Figure 1B). sRAmice displayed preference-aver-
sion behavior that was indistinguishable from control mice, but
total fluid intake remained greatly elevated in sRA mice across
all solute concentrations. Total sodium intake from both food
and drink solutions was similar between sRA and control mice
at hypotonic and hypertonic concentrations, but sodium intake
was greatly increased when sRA mice were offered isotonic
(0.15 M) NaCl. The elevation in sodium intake when offered at
an isotonic concentration may represent a taste-dependent or
a postingestive effect but does not fit the classical definition of
an increased sodium appetite because the sRA mice did not
consume excess sodium when presented at unpalatable, hyper-432 Cell Metabolism 12, 431–442, November 3, 2010 ª2010 Elsevier Inc.tonic concentrations. In addition, sRA
mice consistently produced a large
volume of dilute urine across all solute
concentrations. Urine sodium (UNaC)
and potassium (UKC) concentrations
and urine osmolality were significantly
suppressed in sRA mice (Figure 1B,
see Figure S1 available online). Renal
sympathetic nerve activity (RSNA) was
markedly elevated (Figure 1C), perhaps
as a compensatory mechanism to retain
sodium in the face of an exaggerated
diuresis. Indeed, sRA mice exhibit an8% increase in hematocrit, suggesting that they may be dehy-
drated (Figure 1D). This is unlikely to be due to increased hema-
topoiesis, as renal erythropoietin expression is not elevated in
sRA mice (p = 0.42). Although serum osmolality and serum
potassium concentrations are normal in sRA mice, serum
sodium concentrations are significantly decreased (Figure 1E),
thus suggesting sRA mice exhibit selective, chronic hyponatre-
mia. Interestingly, there is increased lethality associated with
the sRA genotype, as only one in three sRA pups survive until
weaning, suggesting neonatal sRA mice may have difficulty
retaining sodium (Figure 1F).
Dehydration and brain angiotensin-II are known stimuli for the
release of arginine vasopressin (AVP), and the brain RAS is
known to regulate AVP synthesis. Female sRA mice demon-
strated a large elevation in plasma AVP at baseline (Figure 1G).
Whereas male sRA mice did not exhibit increased AVP at base-
line, a brief period (4 hr) of water restriction markedly increased
plasma AVP in sRA but not control mice. We next tested whether
Table 1. Tissue Masses and Endocrine Measures in Adult sRA Mice
Anatomical Measures Control sRA T Test
Body mass (g) 28.53 ± 0.96 (6) 23.94 ± 1.18 (7) p = 0.013
Nose–anus (cm) 9.20 ± 0.13 (6) 9.03 ± 0.16 (7) p = 0.295
Organ Masses
Heart (mg) 112.0 ± 4.7 (6) 113.6 ± 10.3 (7) p = 0.731
(mg/g) 12.15 ± 0.34 12.50 ± 0.91 p = 0.742
Lungs (mg) 182.7 ± 9.2 (6) 136.8 ± 3.6 (7) p < 0.001
(mg/g) 19.85 ± 0.93 15.17 ± 0.38 p < 0.001
Liver (mg) 1285.5 ± 75.6 (6) 1053.4 ± 62.5 (7) p = 0.051
(mg/g) 139.3 ± 6.4 116.4 ± 5.5 p = 0.019
Kidney (mg) 170.2 ± 7.4 (6) 118.1 ± 8.2 (7) p < 0.001
(mg/g) 18.47 ± 0.60 13.03 ± 0.74 p < 0.001
Adrenal gland (mg) 2.7 ± 0.3 (9) 3.8 ± 0.3 (10) p = 0.032
(mg/kg) 83 ± 10 166 ± 15 p < 0.001
Adipose Masses
Interscapular BAT (mg) 61.1 ± 5.2 (6) 48.0 ± 4.1 (7) p = 0.073
(mg/g) 6.64 ± 0.57 5.28 ± 0.37 p = 0.063
Perigenital WAT (mg) 284.0 ± 27.8 (6) 151.4 ± 21.2 (7) p = 0.003
(mg/g) 30.73 ± 2.63 16.60 ± 2.03 p = 0.001
Perirenal WAT (mg) 77.8 ± 16.7 (6) 48.5 ± 10.5 (7) p = 0.154
(mg/g) 8.49 ± 1.87 5.41 ± 1.19 p = 0.179
Mesenteric WAT (mg) 394.1 ± 25.4 (6) 304.9 ± 9.5 (7) p = 0.002
(mg/g) 43.00 ± 3.20 33.75 ± 0.75 p = 0.014
Endocrine Measures
Serum total T3 ng/mL 12.29 ± 1.41 (9) 14.43 ±3.47 (8) p = 0.847
Serum total T4 mg/dL 6.33 ± 1.39 (4) 5.11 ± 1.11 (4) p = 0.520
Serum leptin ng/mL 1.16 ± 0.69 (3) 1.39 ± 0.41 (3) p = 0.788
Plasma insulin (fasted) ng/mL 0.218 ± 0.026 (8) 0.174 ± 0.011 (8) p = 0.148
Blood glucose (fasted) mg/dL 123.6 ± 10.6 (11) 137.3 ± 9.8 (8) p = 0.182
Plasma ACTH ng/mL 5.474 ± 2.235 (6) 1.423 ± 0.689 (5) p = 0.052
Urinary aldosterone ng/mL 23.04 ± 1.59 (8) 20.00 ± 1.82 (8) p = 0.231
ng/day 30.63 ± 4.11 65.99 ± 9.20 p = 0.003
Urinary corticosterone ng/mL 1.15 ± 0.03 (8) 1.61 ± 0.10 (8) p < 0.001
ng/day 1.63 ± 0.27 6.37 ± 1.37 p = 0.004
See also Figure S2.
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over by treating sRA mice with conivaptan, a nonpeptide V1A/V2
receptor antagonist (Vaprisol, 10 mg/kg/day for 3 days). AVP
receptor blockade suppressed sodium intake and preference
for 0.15 M NaCl but had no effect on total fluid intake or urine
output (Figure 1H). Conivaptan also had no effect on serum elec-
trolytes (data not shown). This suggests that AVP has selective
effects on intake behaviors in sRA mice.
Elevated Adrenal Steroids Cause Polydipsia
and Polyuria
Adrenal hormones, particularly steroids, are suggested to play
a role in food intake, metabolic expenditure, and fluid/electrolyte
balance (Mastorakos and Zapanti, 2004). The adrenal glands are
hypertrophied, and steroid levels are elevated in urine from sRACell Mmice (Table 1). We performed bilateral complete adrenalectomy
(ADX) to examine if adrenal steroids are mechanistically
involved in the polydipsia exhibited by sRA mice. Four weeks
after complete removal of adrenal tissue, steroids were no
longer detectable in urine. ADX completely normalized total
fluid and sodium intake, and urine volume and osmolality
(Figure 2A). ADX normalized urine potassium concentration,
and whereas it had no effect on urine sodium concentration, it
completely normalized daily sodium loss (Figure 2B). We treated
a separate cohort of male mice with high doses of either the
mineralocorticoid receptor antagonist, spironolactone, and/or
the progesterone/glucocorticoid receptor antagonist, mifepris-
tone (RU-486), for 4 days to assess the importance of these
signaling pathways. Spironolactone treatment, with or without
cotreatment by mifepristone, significantly blunted total fluidetabolism 12, 431–442, November 3, 2010 ª2010 Elsevier Inc. 433
Figure 2. Adrenal Hormones Are Necessary
for the Hydromineral Phenotypes of sRA
Mice
(A) Total 24 hr fluid intake, sodium intake, urine
volume, and urine osmolality when offered ad
libitum access to tap water and 0.15 M NaCl
(control, n = 7; intact sRA, n = 5; ADX sRA,
n = 4).
(B) Urine potassium concentration (UKC), total
daily potassium loss in the urine (UKV), urine
sodium concentration (UNaC), and total daily
sodium loss in the urine (UNaV).
(C) Total 24 hr fluid intake, sodium intake, and
total daily sodium loss (UNaV) following spirono-
lactone (30 mg/kg/day) and/or mifepristone
(50 mg/kg/day) treatment (males only; control,
n = 15; untreated sRA, n = 15; spironolactone,
n = 5; mifepristone, n = 4; combined, n = 6). *p <
0.05 versus control. yp < 0.05 versus intact/
untreated sRA. All data are mean ± SEM. See
also Table S1.
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magnitude of the effect was small in comparison to full ADX,
possibly due to dose or duration of treatment. In contrast, mife-
pristone treatment had no effects on these endpoints. These
data support a role for adrenal steroids and mineralocorticoid
receptor signaling in the hydromineral phenotypes of the
sRAmouse, though other nonmineralocorticoid, adrenal-derived
hormones (such as various catecholamines) may also be
involved.
sRA Mice Exhibit Increased Energy Expenditure
and Thermogenesis
Concurrent with polydipsia and polyuria, adult sRA mice exhibit
a greatly reduced body mass regardless of sex (Figure 3A). This
reduction is not observed until weaning (Figure 3B).MRI revealed
that adult sRAmice exhibit a profound reduction in both subcuta-
neous and visceral adiposity (Figure 3C). There was a 20%
reduction in adipocyte cross-sectional area within interscapular
brown, perigenital white, and perirenal white adipose pads
(Figure 3D). Despite reduced fat mass at baseline (Table 1), sRA
mice gain weight when fed a high-fat diet (Figure S2).434 Cell Metabolism 12, 431–442, November 3, 2010 ª2010 Elsevier Inc.To identify the mechanism causing
the lean phenotype, we examined both
food intake and energy expenditure.
Over 7 consecutive days in metabolism
cages, sRA mice consumed 7% less
food than littermate controls. However,
since the body masses of sRA mice
were reduced by 25%, they exhibited
hyperphagia and increased fecal output
when the data were normalized to body
mass (Figure 3E, Figure S3). Telemetry
revealed an approximate 1C elevation
of core body temperature during
multiple portions of the light-dark cycle
(Figure 3F). Importantly, this was not
correlated with any genotype-relateddifferences in locomotor activity (Figure 3G), thus providing
evidence that their elevated energy expenditure is due to an
elevation in activity-independent thermogenesis. Oxygen
consumption at thermoneutrality was elevated by 16% in sRA
mice aged 9–12 weeks, during both sleep and stationary wake-
fulness (Figure 3H). The increased metabolic rate in sRA mice
was evident in other cohorts ranging from 15 to 36 weeks of
age (n > 60 in both groups). There was no change in preferred
ambient temperature, suggesting a normal thermoneutral set-
point (Figure S3). sRA mice did not exhibit signs of anxiety
(Figure S3).
Unlike hydromineral phenotypes, bilateral ADX had no effect
on body mass, metabolic rate, food intake, or fecal output of
sRA mice (Figure 4A, Table S1). Mineralocorticoid or glucocorti-
coid receptor antagonists similarly had no effect on these
endpoints. sRA mice exhibited a normal body length, normal
fasting blood glucose and plasma insulin levels, and normal
levels of triiodothyronine (T3) and thyroxine (T4), suggesting
growth hormone and thyroid hormone signaling are not mecha-
nistically involved in the increased metabolism observed in sRA
mice (Table 1).
Figure 3. sRA Mice Are Small and Lean, Primarily Due to a Large Increase in Activity-Independent Energy Expenditure
(A) Body masses of male and female mice 9–22 weeks of age (control males, n = 9; females, n = 6; sRA males, n = 6; females, n = 4).
(B) Body masses of mice at day 17 of gestation (control, n = 15; sRA, n = 8), and 4 weeks (control, n = 9; sRA, n = 4) and 8 weeks (control, n = 17; sRA, n = 9) after
birth.
(C) MRI scans of adult male mice.
(D) Hematoxylin & eosin-stained sections of interscapular brown adipose (BAT), and perigenital and perirenal white adipose (WAT) from adult mice. Scale bars,
100 mm.
(E) Body masses, total 24 hr ad libitum intake of standard chow, and food intake data normalized to body mass (control, n = 12; sRA, n = 8).
(F) Core body temperatures determined by telemetric probes (n = 6 for all).
(G) Spontaneous physical activity determined by telemetric probes.
(H) Metabolic rate, determined by indirect calorimetry (n = 8 for all). *p < 0.05 versus control. All data are mean ± SEM. See also Figure S3.
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Metabolic Rate
We next measured the electrical activity of the sympathetic
nerves (SNA) innervating the interscapular brown adipose tissue
(BAT) and the perigenital white adipose tissue. sRA mice
exhibited a remarkable elevation in BAT SNA (Figure 4B). Unlike
controls, sRA mice were incapable of increasing BAT SNA more
than 2%–3% to stepwise decreases in core temperature
(Figure 4C). Similar trends in SNA were observed in perigenital
white adipose tissue (Figure S4).
We next sought to determine if elevated SNA mediated the
elevation in basal metabolic rate. Acute delivery of the b-adren-
ergic receptor antagonist, propranolol, resulted in large reduc-
tions in metabolic rate (Figure 4D). sRA mice exhibited a robust
dose-dependent response to propranolol, compared to controls
(group3 dose interaction, p = 0.017), indicating increasedmeta-
bolic sensitivity to b-adrenergic blockade and dependency upon
b-adrenergic signaling. Interestingly, expression of uncoupling
protein-1 (UCP-1) mRNA, the typical effector of b-adrenergic
signaling and surrogate marker for sympathetic tone, was notCell Mincreased in BAT from sRA mice (Figure 4E). The reason for
this discrepancy was not immediately obvious, as the expres-
sion of b-adrenergic receptors was normal. Interestingly, expres-
sion of endogenous mouse angiotensinogen, also a known
sympathetic- and cAMP-sensitive gene, was significantly upre-
gulated in BAT. This prompted us to measure other components
of the RAS in BAT. There was no change in the expression of
angiotensin (Ang) II type 1A (AT1A) or Ang-(1-7) (a.k.a. Mas)
receptors. Mouse renin, AT1B, and Ang II type 2 (AT2) receptor
mRNAs were not detected (Figure 4E).
Elevated Brain and Decreased Circulating RAS
Increases Metabolic Rate
Whereas Ang II levels were unchanged in whole-brain homoge-
nates (control 35 ± 7 versus sRA 34 ± 16 pg Ang II/mg protein),
a significant elevation in Ang II was noted in the combined ante-
roventral third ventricle (AV3V) and hypothalamic region of the
brain (control 5.2 ± 0.7 versus sRA 10.5 ± 0.2 pg Ang II / mg
protein, p = 0.002) (Figure 5A). This highlights the regional local-
ization of elevated Ang in sRA mice previously identified byetabolism 12, 431–442, November 3, 2010 ª2010 Elsevier Inc. 435
Figure 4. Elevated Sympathetic Nerve
Activity Contributes to the Metabolic
Phenotypes of sRA Mice
(A) Body masses, metabolic rate, and food intake
4 weeks following bilateral adrenalectomy (ADX)
(control, n = 7; intact sRA, n = 5; ADX sRA, n = 4).
(B) Example tracings from sympathetic nerves
innervating interscapular brown adipose tissue
(BAT), and quantification of BAT sympathetic
nerve activity (SNA) by both frequency analysis
and integrated voltage (RVI) with core tempera-
tures maintained at 37.5C (males only; n = 6 for
all).
(C) BAT SNA RVI from mice with core tempera-
tures decreased to 34C (n = 6 for all).
(D) Metabolic rate, determined by indirect calorim-
etry, following graded doses of propranolol
(control, n = 9; sRA, n = 10).
(E) Gene expression profile from interscapular
brown adipose tissue (BAT) (n = 4 for all). *p <
0.05 versus control. All data are mean ± SEM.
See also Figure S4.
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peptides were significantly suppressed in the circulation
(Figure 5B), likely the result of suppressed renal renin gene
expression (Figure 5C). We hypothesize that this is the result of
chronic hypertension in sRA mice (Figure 5D). We next chroni-
cally infused mice with Ang II to test whether RAS replace-
ment/supplementation would be sufficient to normalize the
metabolic phenotype. Chronic infusion of a nonpressor dose of
Ang II resulted in a decrease in metabolic rate back to the base-436 Cell Metabolism 12, 431–442, November 3, 2010 ª2010 Elsevier Inc.line level of control mice and a significant
shift in respiratory quotient toward the
increased utilization of carbohydrates
(Figure 5E). These data suggest that the
circulating RAS plays a mechanistic role
in metabolic regulation.
Elevated Metabolic Rate in
DOCA-Salt-Treated C57BL/6JMice
In order to establish the physiological
relevance of the sRA mouse model, we
examined metabolic parameters in
a well-established independent model of
hypertension. The deoxycorticosterone
acetate (DOCA)-salt model of hyperten-
sion is known to be dependent upon
increased brain RAS activity and charac-
terized by decreased circulating renin
(Itaya et al., 1986). Consequently, we
hypothesized that DOCA-salt mice
should exhibit metabolic alterations
similar to those of sRA mice. We treated
adult nontransgenic C57BL/6J mice with
subcutaneous DOCA and ad libitum
0.15 M NaCl (DOCA-salt treatment) for
3 weeks. Consistent with our observa-
tions in sRA mice, DOCA salt-treated
C57BL/6Jmice exhibited a large increasein basal metabolic rate (Figure 6A). This was accompanied by
a modest decrease in body mass, a trend toward decreased
interscapular BATmass, and a significant reduction in perigenital
WAT mass (Figure 6B). DOCA-salt-treated mice, like sRA,
exhibited decreased renal renin expression (Figure 6C). Similar
effects of DOCA were observed in female mice (data not shown).
These data demonstrate that sRA mice parallel the phenotypes
of the DOCA-salt model of hypertension (moderate hyperten-
sion, high metabolic rate leading to weight loss, and decreased
Figure 5. Suppression of the Peripheral RAS Contributes to the
Metabolic Phenotypes of sRA Mice
(A) Angiotensin II in whole-brain homogenate (control, n = 5; sRA, n = 7), cortex
(control, n = 4; sRA, n = 4), combined anteroventral third ventricle (AV3V), and
hypothalamic regions (control, n = 4; sRA, n = 3), and brain stem (control, n = 4;
sRA, n = 3).
(B) Plasma RAS peptides (n = 8 for all).
(C) Renal murine renin mRNA expression (n = 4 for all).
(D) Mean arterial blood pressure determined by carotid artery cannula
during anesthesia (control, n = 7; sRA, n = 6), and in conscious, freely
moving mice by radiotelemetry during dark and light phases (control, n = 4;
sRA, n = 4).
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Cell Madiposity), likely through both an elevation in brain RAS activity
and a decrease in circulating RAS activity, thereby underscoring
the physiological relevance of the sRA mouse model.
DISCUSSION
From the data presented here, we conclude that a diverse
but specific set of efferent signaling modalities are activated by
brain RAS hyperactivity, and combinations of these signals
converge to elicit the robust alterations in fluid and energy
balance in the sRA mouse model. A schematic representation
of these pathways is illustrated in Figure 6D. While adrenal
steroids are absolutely necessary for the maintenance of poly-
dipsia and polyuria in these animals, these hormones are
dispensable for the increased energy expenditure of sRA mice.
In contrast, the metabolic phenotypes of sRA mice are the result
of elevated sympathetic nerve activity and a suppression of the
peripheral RAS. Further validation for this mechanism comes
from the observation that the metabolic phenotypes of sRA
mice are replicated in an independent model of neurogenic
hypertension caused by an elevated brain and depressed circu-
lating RAS.
Hydromineral Regulation by the Brain RAS
The hydromineral phenotypes of sRA mice are the result of
a combination of brain RAS signaling and peripheral steroids.
We previously demonstrated the dependence of the polydipsia
in these animals upon both brain AT1 stimulation and hyperac-
tivity of the RAS within the subfornical organ (Sakai et al.,
2007), and here we have demonstrated the necessity of adrenal
steroids in these behaviors. This synergy of adrenal steroids and
brain Ang has previously been documented in rats, as coadmin-
istration of peripheral steroids and brain Ang II synergize to
elicit robust drinking responses (Epstein 1982; Fluharty and
Epstein 1983; Johnson et al., 2003; Krause and Sakai, 2007).
This overlap of thirst mechanisms between mice and rats is
important to note, as many investigators have previously docu-
mented that while peripheral Ang peptides are potent dipsogens
in rats, and both species exhibit robust responses to intra- and
extracellular dehydration, mice are largely insensitive to periph-
eral Ang (Hoshishima et al., 1962; Kobayashi et al., 1979;
Rowland, 1986; Rowland and Fregly, 1988). Presumably the
synergy between brain angiotensinergic signaling and adrenal
steroids is mediated through mineralocorticoid regulation of
brain AT1 receptors (Thornton et al., 2007). Others have
demonstrated binding sites for adrenal steroids in brain regions
involved in water and sodium intake (Birmingham et al., 1979;
Gerlach and McEwen, 1972; McEwen et al., 1986), and interfer-
ence with brain mineralocorticoid receptor activation (McEwen
et al., 1986) or gene expression (Sakai et al., 2000) has inhibitory
effects on hydromineral phenotypes in rats. Thus, the determina-
tion here that ADX, and more specifically mineralocorticoid
receptor antagonism, attenuates the hydromineral phenotypes(E) Metabolic rate and respiratory quotient following angiotensin II treatment
(100 ng/kg/min, s.c., for 8 weeks; males only; control saline, Ang II N = 4
each; sRA saline, n = 7; sRA Ang II, n = 3). *p < 0.05 versus control. yp %
0.05 versus saline-treated sRA. All data are mean ± SEM.
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Figure 6. DOCA-Salt-Treated C57BL/6J Mice Exhibit Similar Phenotypes to sRA Mice, and a Working Model
Adult C57BL/6J male mice were treated for 3 weeks with DOCA-salt (n = 3 for all).
(A) Metabolic rate determined by indirect calorimetry.
(B) Body masses, interscapular brown adipose, and perigenital white adipose tissue masses.
(C) Renal murine renin mRNA expression (*p < 0.05 versus sham; all data are mean ± SEM).
(D) A working model for the efferent mechanisms mediating the elevated fluid turnover, hypertension, and elevated metabolic rate in sRA mice. Interventions
supporting this model include adrenalectomy (ADX), spironolactone-mediated blockade of mineralocorticoid receptors (MR antagonism), intracerebroventricular
blockade of angiotensin receptors (ARB, from Sakai et al., 2007), propranolol-mediated blockade of b-adrenergic signaling (b-AR antagonism), and chronic
subcutaneous angiotensin II supplementation (Ang II infusion).
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Additional studies will nevertheless be required to directly test
if the responses to mineralocorticoids are mediated within the
brain.
The mechanism by which adrenal steroids are elevated in sRA
mice is unclear. ACTH, vasopressin, interleukin-6, and tumor
necrosis factor-a all participate in the regulation of corticoste-
rone levels (Tanoue et al., 2004; Judd et al., 2000), while circu-
lating and local adrenal RAS activity, potassium, corticotropin,
catecholamines, and prostaglandins all contribute to the regula-
tion of aldosterone levels (Willenberg et al., 2008). Vasopressin is
known to regulate steroid production through modulation of
ACTH levels, but plasma ACTH levels were depressed in sRA
mice (Table 1). We considered the possibility that ectopic
expression of the hREN transgene may cause local RAS hyper-
activity in the adrenal gland. We previously reported that hREN
was not detected in the adrenal glands of sR mice (Morimoto
et al., 2002). Nevertheless, we examined adrenal expression of
human and mouse renin by real-time RT-PCR and determined
that while the sR construct is expressed, its level of expression
is 1000-fold lower than its expression in the brain, and 30-fold
lower than expression of endogenous mouse renin in the adrenal438 Cell Metabolism 12, 431–442, November 3, 2010 ª2010 Elseviergland (Table S2). These data rule out ectopic expression of hREN
in the adrenal gland as a cause for adrenal hypertrophy and ele-
vated steroid levels in sRA mice. We also considered the possi-
bility that there may be altered circadian rhythms in the adrenal
gland of sRAmice. Doi, et al. (2010) recently reported that expres-
sion of 3b-hydroxyl-steroid dehydrogenase type 6 (Hsd3b6) but
not Hsd3b1 is regulated by the circadian clock. Deficiency
of the core clock components Cryptochrome-1 and -2 resulted
in aldosterone-dependent hypertension through markedly in-
creased expression of Hsd3b6. Unlike their study, we found no
evidence for altered Hsd3b6 or Hsd3b1 expression in adrenal
gland (Table S2). This is consistent with other data endpoints
suggesting a retention of circadian rhythms in sRAmice (Figures
3F, 3G, and 5D). Sympathetic stimulation of adrenal glands
may also play a role in the elevated adrenal steroid production.
Preliminary studies utilizing the a-adrenergic antagonist, prazo-
sin, suggest no effect on steroid levels, although it was previ-
ously reported that sympathetic regulation of adrenal steroid
production is mediated through b-adrenergic (and possibly
dopaminergic) stimulation of cAMP signaling (Pratt et al., 1985;
Bugajski et al., 1991; Missale et al., 1990; Ehrhart-Bornstein
et al., 1995), and thus catecholaminergic signaling mayInc.
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tion in sRA mice.
Metabolic Regulation by the Brain RAS
The metabolic phenotypes of sRA mice are dependent upon
a combination of elevated sympathetic nerve activity and
suppression of the peripheral RAS, as blockade of b-adrenergic
signaling or supplementation with subcutaneous angiotensin II
both corrected the elevation in basal metabolic rate in sRA
mice. The decrease in renal renin expression and circulating
Ang was at first puzzling, given the remarkable increase in
RSNA. Indeed, renal renin production is regulated through
many inputs, including endothelin-1, Ang II, mechanical stretch,
inflammatory cytokines, a- and b-adrenergic stimulation, salt,
and renal perfusion pressure (Pan and Gross, 2005). We hypoth-
esize that the chronic hypertension in this model is the primary
cause for decreased renal renin production in the sRA mouse
model, just as it appears to be in the DOCA-salt model (Goodwin
et al., 1969, Makrides et al., 1988).
Previous investigators have demonstrated that global
knockout of the genes encoding renin (Takahashi et al., 2007),
angiotensinogen (Massiera et al., 2001), angiotensin-converting
enzyme (Jayasooriya et al., 2008), AT1A receptors (Kouyama
et al., 2005), AT2 receptors (Yvan-Charvet et al., 2005), or the
Mas receptor (Santos et al., 2008b) results in lean phenotypes
and/or resistance to weight gain. Thus, we originally hypothe-
sized that sRA mice, with increased RAS activity in the brain,
might exhibit weight gain when compared to control littermates.
Discovering that the sRA mice are lean and exhibit many of the
characteristics of mouse models of global RAS knockout, we
investigated the activity of the circulating RAS. We determined
that two indexes of circulating RAS activity (circulating Ang II
and renal renin expression) were greatly suppressed. Conse-
quently, from the standpoint of the circulating RAS, our model
phenocopies models of RAS deficiency or blockade. Impor-
tantly, we also documented an inverse correlation between
circulating RAS activity and metabolic rate in the DOCA-salt
model, a well-documented experimental model of neurogenic
hypertension (Itaya et al., 1986). The determination that hyperac-
tivity of the brain RAS and hypoactivity of the peripheral RAS
results in a negative energy balance is also in agreement with
previous findings from studies in rats utilizing brain Ang infusion
(Porter et al., 2003; Porter and Potratz 2004), peripheral pharma-
cological inhibition of Ang-converting enzyme (ACE) (Weisinger
et al., 2008; Santos et al., 2008a; Carter et al., 2004), and periph-
eral pharmacological antagonism of AT1 receptors (Zorad et al.,
2006). Weight loss in humans in response to ACE inhibition
(Beevers, 1984) or AT1 receptor antagonism (Shimabukuro
et al., 2007) has also been reported previously. Interestingly,
double transgenic mice from our laboratory which exhibit RAS
hyperactivity throughout the body including the brain, and there-
fore do not have a suppressed circulating RAS (Merrill et al.,
1996), exhibit normal bodymasses (25–27 weeks of age; control,
31.2 ± 1.2 g, n = 9; double transgenic, 29.7 ± 1.3 g, n = 5, p =
0.46). It appears that regardless of mechanism (genetic deletion,
pharmacological inhibition or antagonism, feedback inhibition,
or suppression due to elevated brain RAS activity), suppression
of the peripheral RAS elicits increased metabolic rate, altered
adipose development, and generally a negative energy balance.Cell MConclusions, Implications, and Future Directions
Significant evidence supports the existence of a local RASwithin
the brain of rodents and humans (reviewed in Grobe et al., 2008).
Evidence also directly supports the function of the brain RAS in
the physiological and pathophysiological regulation of fluid
balance and energy metabolism, though the mechanisms medi-
ating these phenotypes were largely unknown. Here we have
demonstrated robust hydromineral and metabolic conse-
quences of brain RAS hyperactivity in mice, and identified the
efferent signaling mechanisms involved in the modulation of
these endpoints. From these findings, we hypothesize selective
participation by fore-/midbrain versus hindbrain regions in the
regulation of hydromineral and metabolic endpoints. Further,
we hypothesize the involvement of altered brain RAS signaling
in the hydromineral and metabolic consequences of various
high- and low-renin forms of hypertension and the metabolic
syndrome.EXPERIMENTAL PROCEDURES
Animals
Double-transgenic sRA mice were generated as previously described (Sakai
et al., 2007). C57BL/6J mice expressing human renin via the synapsin
promoter (sR mice) were crossed with mice expressing human angiotensino-
gen via its own promoter (A mice). A closely related mousemodel (sRAflox) was
also used, in which the A strain is replaced by a human angiotensinogen
construct in which exon 2 of the gene is flanked by LoxP sequences (Aflox).
Just as with A mice, Aflox mice are phenotypically normal, unless human renin
is also present. sRAflox mice have the samemetabolic, blood pressure, and hy-
dromineral phenotypes as sRAmice, and thus sRA and sRAflox lines were used
interchangeably. MRI imaging, histological examinations, high-fat diet, radio-
telemetric core temperature and activity, quantitative RT-PCR from adipose
and renal samples, and plasma hormones were determined only with the
sRA line. Sympathetic nerve recordings, Ang II replacement, and propranolol
treatment were performed in the sRAflox line. Baseline metabolic endpoints
were examined using both lines. Single-transgenic (sR, A and Aflox) and non-
transgenic littermate mice are phenotypically normal for every endpoint exam-
ined, and have thus been combined into a single control group for all studies.
Both sexes of mice were utilized for all endpoints, with the exceptions that only
males were used for steroid antagonist injections, sympathetic nerve activity
recordings, and angiotensin II infusions. All animals were housed in shoebox
style forced-air cages, with ad libitum access to standard chow and water at
all times, unless otherwise noted. Lighting was maintained on a standard
12:12 hr cycle, and housing and experimental rooms were maintained
between 23C and 25C and 10% and 40% humidity. All procedures per-
formed herein were approved by the University of Iowa’s Institutional Animal
Care and Use Committee.
MRI
Adipose imaging by magnetic resonance was performed as previously
described (Morgan et al., 2008; Rahmouni et al., 2008). Mice were anesthe-
tized using a mixture of ketamine and xylazine (87.5 and 12.5 mg/kg, i.p.),
and images were captured in the axial and coronal planes with a Varian
Unity/Inova 4.7 T small-bore MRI system (Varian, Palo Alto, CA), using a
T1-weighted fast spin-echo sequence (TR/TE = 625/12 ms) with in-plane reso-
lution of 0.13 3 0.25 mm2 and slice thickness of 1 mm.
Metabolic Cages
Mice were acclimated to Nalgene (Rochester, NY) single-mouse-sized metab-
olism cages for at least 2 days before any studies were performed. All animals
received ad libitum access to powdered chow (Harlan Teklad, NIH-31 modi-
fied 6% mouse/rat diet), water, and NaCl drink solutions (0.00–0.50 M, for
two-bottle choice tests). Bottle positions were alternated daily during two-
bottle choice paradigms, to account for side biases.etabolism 12, 431–442, November 3, 2010 ª2010 Elsevier Inc. 439
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Animals were placed into a water-jacketed 2 L beaker (Ace Glass, Vineland,
NJ) maintained at 30C, and room air was drawn through the chamber at
300 mL/min (R2 flow control, AEI). Air samples were dried by passage through
two successive columns of CaSO4 (Drierite, Arcos) dessicant, then analyzed
for CO2 (CD-31, AEI) and O2 (S-3A/II, AEI) content. Data were recorded and
analyzed using a PowerLab (ADInstruments) and associated Chart software
on a PC computer.
Telemetric Blood Pressure
Mice were anesthetized with ketamine/xylazine, and a radiotelemetric blood
pressure probe (DSI, Model TA11PA-C10) was implanted into the common
carotid artery, as previously (Halabi et al., 2008). The telemeter was within
the abdomen, and animals were allowed to recover for 2 days. Blood pressure
and heart rate data were collected for 30 s every 5 min and recorded using the
Dataquest program (DSI) on a PC computer. Data were collapsed within
animal across 2 days of recording for statistical analyses.
Telemetric Core Temperature
Animals were anesthetized using ketamine/xylazine. Amidline incision through
the abdominal wall was made, and a radiotelemetric probe (Model TA10TA-
F20, DSI) was inserted. The abdominal wall and the overlying skin were sepa-
rately sutured shut, and singly housed animals were allowed 1 week of
recovery. Following recovery, the home cages of the animals were placed
on top of receiver platforms (DSI). Core temperature and physical activity
data (30 s every 5min) were recorded using the associatedDataquest program
(DSI) on a PC computer. Individual time points from 5 consecutive days were
collapsed within each animal for statistical analyses.
Hormone Assays
Urine collected during metabolism cage studies, serum (trunk blood collected
into clean microcentrifuge tubes allowed to stand 5 min before a 5 min centri-
fugation at 50003g), andplasma (400 ml trunk blood collected into amicrocen-
trifuge tube containing 50 ml 0.5 M EDTA, gently mixed, then immediately
centrifuged for 5 min at 5000 3 g) were analyzed for various hormones.
Hormones were analyzed by selective ELISAs, as per the manufacturer’s
instructions, including urine corticosterone and aldosterone (Cayman Chemi-
cal), serum total triiodothyronine (T3) and thyroxine (T4) (Alpco), plasma leptin
(Crystal Chem), plasma insulin (Alpco), and plasma ACTH (Bachem). Blood
glucose levels were determined using an Accu-Check meter (Roche).
Sympathetic Nerve Activity
Sympathetic nerve recordings were performed as previously described
(Morgan et al., 2008; Rahmouni et al., 2008).Mice were anesthetized using ket-
amine/xylazine and instrumented with a colonic temperature probe. The left
carotid artery and jugular veins were cannulated, and the brown adipose
pad was exposed. A sympathetic nerve innervating the brown adipose was
isolated and suspended on a 36-gauge platinum-iridium electrode and
secured in place with silicone gel (World Precision Instruments). Electrodes
were attached to a high-impedance probe (HIP-511, Grass Instruments),
and the nerve signal was amplified (0.5–1.0 3 105 for RSNA, 5.5 3 106 for
BAT, 6.0 3 105 for WAT) with a Grass P5 AC preamplifier, filtered at a 100
and 1000 Hz cutoff, and routed to a resetting voltage integrator (model
B600c, University of Iowa Bioengineering). Data were recorded and analyzed
using a PowerLab unit and associated Chart software (ADInstruments) on
a Macintosh computer.
Gene Expression
Total RNA was extracted using TriReagent (Molecular Research Center). RNA
was then treated with DNase I (Fermentas), and cDNA generated by reverse
transcriptase using Superscript III (Invitrogen). Real-time PCR was performed
using primer/probe sets from Applied Biosystems, and gene expression was
determined by the Livak method (Livak and Schmittgen, 2001).
RAS Peptide Analyses
After isolation from whole blood as above, 150 ml of plasma was diluted with
15 ml of methanol and rapidly frozen at 80C. Plasma samples were then
analyzed by HPLC as previously described (Cassis et al., 2004; Daugherty440 Cell Metabolism 12, 431–442, November 3, 2010 ª2010 Elsevieret al., 2004). Tissues were snap frozen in liquid nitrogen, homogenized in
0.1 N HCl containing 0.5 mM o-phenanthroline and 0.1 mM pepstatin. After
centrifugation (20,000 3 g, 20 min, 4C), the supernatant was placed at
20C overnight, and centrifugation was repeated the next day. The superna-
tant was diluted (1:1) with 0.1%orthophosphoric acid and stored at 4C for 6 hr
before centrifugation a final time at 20,000 3 g (4C). The supernatant was
diluted with 0.02% orthophosphoric acid before applying to C18minicolumns.
Tissue extracts and plasma were then purified by passage through a C18
column. Angiotensin peptides were then resolved using an HPLC system
with ultraviolet detection (254 nm). The mobile phase at time 0 was 20% buffer
A (0.05% trifluoroacetic acid), 80% buffer B (100% acetonitrile). Gradient
elution was achieved by increasing the concentration of buffer B to 40%
over 30 min, followed by 100% buffer B for 15 min to clean the column. With
each set of plasma samples, a set of angiotensin standards (Ang II, Ang-
(2-8), Ang-(3-8), Ang-(4-8), Ang-(5-8), 5 mg/ml each; Sigma) was injected
onto the system to define angiotensin peptide retention times. A buffer blank
was injected and collected intermittently to check for carryover of peptides
across individual runs. Fractions (0.5mL) from the HPLCwere collected, evap-
orated to dryness, and reconstituted for Ang II RIA.
Bilateral Adrenalectomy
Adult sRA and littermate control mice, between 20 and 30 weeks of age,
underwent bilateral ADX. For 2 days preceding and 1 day following surgery,
mice were injected i.p. daily with 20 mg dexamethasone. Mice were anesthe-
tized with ketamine/xylazine. The adrenals were exposed through bilateral
dorsal incisions, isolated by silk suture, and removed by cautery, and the
muscle wall and skin were closed separately with silk suture. Mice were
then housed singly, with ad libitum access to food, tap water, and 0.15 M
NaCl for 4 weeks. Four control and four sRA mice survived to the end of the
experiment following ADX (44% and 36% survival after ADX, respectively).
DOCA-Salt Model
Ten-week-old wild-type C57BL/6J mice were anesthetized with ketamine/
xylazine and a pellet of DOCA (50 mg 3 21 days, Innovative Research of
America) was implanted subcutaneously. Notably, animals were not unineph-
rectomized for this study. Animals were allowed ad libitum access to chow, tap
water, and 0.15 mM NaCl for 4 weeks.
Statistical Analyses
Data were analyzed by one- or two-way ANOVA (with/without repeated
measures), with p < 0.05 considered significant. Bonferroni post hoc analyses
were used when main effects reached significance. Nonparametric analyses
(Mann-Whitney, Friedman’s ANOVA) were utilized when data failed normality
or equal variance tests.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and two tables and can be
found with this article at doi:10.1016/j.cmet.2010.09.011.
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